Organon & Co | OGN - بدهی های جاری

قیمت سهام
6.35
تغییر روزانه
0.02 0.32%
ماهیانه
-12.77%
سالیانه
-58.62%
Q1 پیش بینی
6.16




بدهی های جاری تغییر دادن تاریخ
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.11B 478.47M 2025-06
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Merck USD 28.63B 2.59B 2025-09
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Novartis USD 32B 286M 2025-09
Organigram Holdings CAD 126.16M 18.88M 2025-09
Organon & Co USD 2.68B 117M 2025-09
Ovoca Bio EUR 2.44M 1.1M 2022-06
Pharma Mar EUR 93.88M 4.94M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 280.3M 18.13M 2025-03